Akums Drugs & Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹9,591 cr
- P/E
- 37.58×
- ROE
- 7.70%
- Debt / equity
- 0.02
- Div yield
- 0.49%
- 52-week range
- 409.30 — 639.00
Company snapshot
Akums Drugs & Pharmaceuticals Ltd.
Pharmaceuticals
₹8,190 cr
P/E 32.09×
Latest quarter · Mar 2026
Sales₹1,158 cr
Net profit₹81 cr
Op. margin+13.1%
EPS₹5.53
Strength & growth
Debt / equity0.00×
Current ratio2.54×
The timeline — 2 notes on Akums Drugs & Pharmaceuticals Ltd.
May 2026
- 21 May 26 · 12:41 PM IST Brief Brief · Earnings · Mid cap
Akums FY26 call transcript adds nothing new after earlier disclosure
The full transcript of the Q4 FY26 call confirms results already known. No material surprise for the market.
- 20 May 26 · 7:09 PM IST Brief Brief · Order Wins · Mid cap
Akums gets ₹133.75 cr tax notice, says it will appeal
IT assessment demands 52% of FY26 profit, but management calls it unsustainable and plans to challenge.